公司資料
InVivo Therapeutics 股價、新聞與催化劑
- 股票代碼:
- NVIV
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 NVIV 的收盤價變動背景。
公司概覽
業務概覽
InVivo Therapeutics is a medical technology company focused on spinal cord injury and neurotrauma-related devices or therapies. Its business has centered on nervous-system repair rather than classic therapeutics.
所在地與產業分類
InVivo Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in neurotechnology and medical devices.
商業模式特徵
The company depends on product or therapy development, clinical progress, and the ability to maintain a viable path in a difficult indication. Investors usually watch regulatory updates, commercialization strategy, and capital runway.
生技產業定位
InVivo occupies a niche neurorepair position within healthcare innovation. It is not a typical biotech drug stock, but it remains tied to a high-unmet-need clinical area.
未來催化劑
- InVivo Therapeutics is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live spine-program milestone. The market is mainly focused on residual value.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。